•Casereport•Panicattacks10yearsafterhearttransplantationsuccessfullytreatedwithlow-dosecitalopram:acasereportChenyuYE1,YaminZHUANG2,JianlinJI1,HaoCHEN2,*1DepartmentofMedicalPsychology,FudanUniversityAffiliatedZhongshanHospital,Shanghai,China2DepartmentofCardiacSurgery,FudanUniversityAffiliatedZhongshanHospital,Shanghai,China*correspondence:chen.hao2@zs-hospital.sh.cnAfull-textChinesetranslationofthisarticlewillbeavailableathttp://dx.doi.org/10.11919/j.issn.1002-0829.215021onApril25,2016.Summary:Panicattacksarecommonamongpatientswhohaveundergonehearttransplantation,buttherearenoclinicalguidelinesforthetreatmentofpanicattacksinthisgroupofpatients.Thisreportdescribesa22-year-oldwomanwhoexperiencedpanicattacks10yearsafterhearttransplantsurgery.Theattacksstartedaftershediscoveredthattheaveragepost-transplantationsurvivalis10years.Treatedwithcitalopram10mg/d,hersymptomsimprovedsignificantlyafter2weeksandhadcompletelyresolvedafter8weeks.Apositivephysician-patientrelationshipwiththedoctorswhoregularlyfollowedhermedicalconditionwascrucialtoencouraginghertoadheretothetreatmentwithcitalopram.Shecontinuedtakingthecitalopramfor7monthswithoutanyadverseeffects.Whenfollowedup3monthsafterstoppingthecitalopram,shehadhadnorecurrenceofthepanicattacks.Keywords:hearttransplantation;panicattacks;citalopram;China[ShanghaiArchPsychiatry.2015;27(6):378-380.doi:http://dx.doi.org/10.11919/j.issn.1002-0829.215021]ShanghaiArchivesofPsychiatry,2015,Vol.27,No.6•378•1.IntroductionAnxietyanddepressionarecommonamongrecipientsofhearttransplantsurgery.[1-4]Theprevalenceofpanicattacksisabout8%inthesepatients.[4]Wepresentthecaseofayoungfemalewhoexperiencedpanicattacks10yearsafterhearttransplantationthatweresuccessfullytreatedwithlow-dosecitalopram.2.CasehistoryA22-year-oldwomanwhohadundergonehearttransplantsurgeryinOctober2005whenshewas12yearsoldhadbeeninexcellenthealthduringthefirstnineyearsoffollow-up,butshestartedhavingpanicattacksinNovember2014.Onenightshesuddenlyexperiencedtightnessinherchest,palpitations,shortnessofbreath,andprofusesweatingwithnoobvioustriggers.Shewasimmediatelytakentotheemergencydepartmentwhereanextensiveclinicalexamandlaboratorytestsfoundnoabnormalities:herliverandkidneyfunction,electrolytes,cardiacenzymes,andD-dimerswereallnormal;andanelectrocardiogram(ECG)showedaheartrateof110beatsperminute,leftatrialenlargement,atrioventricularnodalreentranttachycardia,andT-wavechanges(normalfindingsafterhearttransplantsurgery).Shewasgivenoxygenbymaskforhalfanhouranddischargedafterthesymptomsresolved.Duringthenextweeksheexperiencedrepeatedpanicattackseverytwodays,mostofwhichoccurredpriortobedtime,andallofwhichresultedinemergencyroomvisitswherenoabnormalitieswereidentifiedandthesymptomsresolvedafter30minutesofoxygenbymask.Followingthesuggestionoftheemergencyroomphysicians,sheboughtahomeoxygengeneratorsoshecouldtakeoxygenatbedtime,butthepanicattacksandemergencyroomvisitscontinuedtooccureverytwodays.AfewweekslaterinearlyDecember2014,shecametothehearttransplantsurgeryunitforaroutineoutpatientfollow-upvisit.Herheartultrasoundtestrevealedanejectionfractionof67%(normalrangeis>55%);herbrainnatriureticpeptide(BNP)was137μg/ml(ameasureofheartfailurethatisnormallybelow1000μg/mlinpersonswhohaveundergonehearttransplantation);thebloodlevelsofanti-rejectiondrugswerewithinthereferenceranges;androutinebloodtestsandliverandkidneyfunctiontestswereallwithinnormallimits.Thus,therewasnoclearphysicalcauseforthepanicattacks.Furtherinquiryintothehistoryrevealedtheprobabletriggerforthepanicattacks.Afterhertransplantshehadbeenadiligentstudentandeventuallygraduatedfromcollege.Startingacoupleofmonthsearlier(inAugust2014)shebeganworkingasafinancialofficeratasmallfirmwherenooneShanghaiArchivesofPsychiatry,2015,Vol.27,No.6•379•knewofhermedicalcondition.TheninOctober2014byhappenstanceshelearnedthattheaveragelifeexpectancyofhearttransplantrecipientsisabout10yearsbeyondthesurgery.Giventhatshehadjustcompleted10yearspost-surgeryfollow-up,thisinformationwasamajorshockforher.Shebecameveryanxious,andbeforelongthepanicattacksbegantooccur.Giventhenormalphysicalfindingsinthepresenceofrelativelyseverepanicattacks,herdoctoratthetransplantsurgeryunitrecommendedimmediateassessmentatthehospital’sdepartmentofmedicalpsychology.Shewasdiagnosedwithpanicdisorderbyanattendingpsychiatrist(usingcriteriaofthe5theditionoftheDiagnosticandStatisticalManualoftheAmericanPsychiatricAssociation,DSM-5[5])andcompletedChineseversionsoftheHamiltonAnxietyScale(HAMA)[6]andtheHamiltonRatingScaleforDepression(HAMD)[6]whichindicatedmoderateanxietyandmilddepression(scoresof23onHAMAand13onHAMD).Sherefusedanyformofpsychotherapy,butafterencouragementfromherdoctoratthetransplantationclinicandfamilymembers,sheagreedtotakemedicationsupervisedbypsychiatristsatthehospital’spsychologyclinic.Shewasstartedoncitalopram5mg/d;afteroneweekthiswasincreasedto10mg/d.Aftertwoweeksoncitalopramshereportednoadversereactionsandindicatedthattheepisodesofpanicwerelessfrequentandlesssevere.Sheoccasionallyexperiencedtightnessofthechestandpalpitations,butthesesymptomswouldabateafteradministeringoxygenfor10minutesinherhomeanddidnotrequireemergencyroomvisits.Afollow-upassessmentwithHAMAandHAMDaftertakingcitalopramfortwoweeksshowedthatthescoreshaddroppedto15and10,respectively,indicatingcontinuingmildanxietyandmilddepression.Sheexpressedconcernsaboutthesafetyoflong-termuseofcitalopramandwasunwillingtocontinuegoingtothepsychologicalclinicbecauseshedidnotbelieveshehadanypsychologicalproblems.Nevertheless,withencouragementandreassurancefromthedoctorsatthetransplantationclinicwhohadfollowedherheartconditionformanyyears,shecontinuedtotakethecitalopramat10mg/dassupervisedbycliniciansatthehospital’spsychologicalclinic.After8weeksoftreatmentshereportedacompletedisappearanceofsymptomsanddidnotreportanysideeffects.Shewasabletoattendworkeverydayandperformedwellonthejob,butshestillusedoxygenathomeeverynighttopreventpanicattacks.HerHAMAscorehaddecreasedto9andherHAMDscorehaddecreasedto7,bothwithinthenormalrange.After12weeksoftreatmentshereportedfeelingnormalandaskedtodiscontinuethecitalopram,butwiththeencouragementofherdoctorsshecontinuedtotakethecitalopramforanother4months(thatis,foratotalofmorethan7months).Whenfollowedup3monthsafterstoppingthecitalopram,shehadhadnorecurrenceofthepanicsymptomsandwasfunctioningwellatherjob.3.DiscussionPanicattacksarerelativelycommonamongrecipientsofhearttransplantsurgery,buttherearenoguidelinesorliteraturethatdiscussesstepsforhandlingpanicattacksinthisuniquepatientpopulation.Onereportondepressionafterhearttransplantation[7]foundthat92%oftransplantrecipientswithadiagnosisofclinicaldepressionreceivedpharmacologicaltreatment(primarilyselectiveserotoninre-uptakeinhibitors[SSRIs]),butthestudydidnotcomparetheefficacyofdifferenttypesofmedicationsanddidnotrecommendanyparticularmedication.Onearticlepublished10yearsagosuggestedthatcitalopramandmirtazapinemaybebetterthanotherantidepressantsfortreatingdepressioninhearttransplantrecipients,[8]buttheauthorsacknowledgedthelackofwell-designedstudiesthatcouldconfirmthisrecommendation.AreviewbyRustadandcolleagues[9]foundthatSSRIsareusuallysafeandeffectiveforindividualswithchronicheartfailurewhohaveconcurrentdepression.Anotherstudyreportednoadversereactionswhenusingcitalopramamongelderlypersonswithcomorbiddepressionandchronicheartfailure.[10]Takentogether,thesestudiessuggestthatcitaloprammayhaveanadvantageasatreatmentfordepressionamongindividualswhoarehearttransplantrecipients.InChinacitalopramisnotapprovedforuseinpanicattacks,butthereisagrowinginternationalliteratureconfirmingitseffectivenessinthetreatmentofpanicattacks[11,12]andseveralEuropeancountrieshavealreadyapprovedpanicattacksasoneoftheindicationsforcitalopram.Intheabsenceofevidence-basedclinicalguidelinesfortreatingpanicattacksamongindividualswhohavehadcardiactransplantations,theeffectivenessandsafetyofcitalopramamongelderlypatientswithcardiacfailuremakesitoneofthebesttreatmentoptionsforpatientswithcardiactransplantations.Inthiscaseaninitialdosageofcitalopramof5mg/dwasincreasedto10mg/dinthesecondweekandsubsequentlysustainedatthatdosage.Thiswassufficienttoresultinanexcellentclinicaloutcomewithin8weekswithouttheemergenceofadverseeffects.Therearenorecommendationsaboutthedosageanddurationoftreatmentofpanicepisodesinpatientswithcardiactransplantation,sowedecidedtofollowgeneralclinicalguidelinesinChinafortreatinganxietydisorderswhichrecommendthatpatientsstayonmaintenancemedicationforonetotwoyears.[13]However,thepatientwasreluctanttocontinuetakingmedicationsothetreatmentonlycontinuedfor7months.Psychotherapeuticinterventionsmayalsobeuseful.Onestudyfoundthatcognitivebehavioraltherapymightbeeffectivefordepressionafterhearttransplantation.[7]Inthecasereportpresentedinthispaper,itisprobablethatpsychologicaltriggersinducedthepanicattacks.However,theyoungwomandeniedthatshehadpsychologicalproblemsandadamantlyrefusedpsychotherapy.ThemedicaldoctorswhoregularlyfollowedthestatusofherhearttransplantationprovidedtheempatheticpsychologicalsupportandhealtheducationaboutherpanicattacksthatensuredShanghaiArchivesofPsychiatry,2015,Vol.27,No.6•380•heradherencetothetreatmentwithcitalopram.Theexistenceofthisstrong,trustingrelationshipwithhermedicaldoctorswasanessentialfactorinthesuccessfultreatmentofherpanicattacks.FundingNofundingwasobtainedforpreparingthiscasereport.ConflictofintereststatementTheauthorsdeclarenoconflictofinterestrelatedtothismanuscript.InformedconsentThepatientsignedaninformedconsentformandagreedtothepublicationofthiscasereport.Authors’contributionCYandYZwrotetheinitialdraftofthiscasereport,HCprovidedinsightsaboutthepatient’shistory,JJprovidedimportantcommentsonthedraft,andallauthorsapprovedthefinalmanuscript.概述：在接受心脏移植的患者中，惊恐发作是很常见的，但对于这些患者的惊恐发作，没有专门的临床治疗指南。本文报告了一例22岁女性在心脏移植术后10年发生惊恐发作。患者得知心脏移植后平均存活时间是10年之后，出现了惊恐发作。予以西酞普兰10mg/d治疗，2周后症状明显好转，8周后症状完全消失。定期随访、医患关系良好对鼓励患者坚持西酞普兰治疗至关重要。患者持续服用西酞普兰7个月，无明显不良反应。在停用西酞普兰3个月后随访时，惊恐发作未复发。关键词：心脏移植；惊恐发作；西酞普兰；中国本文全文中文版从2016年4月25日起在http://dx.doi.org/10.11919/j.issn.1002-0829.215021可供免费阅览下载小剂量西酞普兰成功治疗心脏移植术后10年惊恐发作1例叶尘宇,庄亚敏,季建林,陈昊References1.DewMA,RothLH,SchulbergHC,SimmonsRG,KormosRL,TrzepaczPT,etal.Prevalenceandpredictorsofdepressionandanxiety-relateddisordersduringtheyearafterhearttransplantation.GenHospPsychiatry.1996;18(6Suppl):48S-61S2.DewMA,KormosRL,DiMartiniAF,SwitzerGE,SchulbergHC,RothLH,etal.Prevalenceandriskofdepressionandanxiety-relateddisordersduringthefirstthreeyearsafterhearttransplantation.Psychosomatics.2001;42(4):300-3133.YeCY,LinY,WangYL,ChenY.[Thedepressionandanxietystateofhearttransplantationpatients].ZhongHuaQiGuanYiZhiZaZhi.2012;33(01):41-43.Chinese4.DewM,DiMartiniA,DabbsAD,FoxDR,MyaskovskyL,PoslusznyDM,etal.Onsetandriskfactorsforanxietyanddepressionduringthefirst2yearsafterlungtransplantation.GenHospPsychiatry.2012;34(2):127-138.doi:http://dx.doi.org/10.1016/j.genhosppsych.2011.11.0095.AmericanPsychiatricAssociation.DiagnosticandStatisticalManualofMentalDisorders,5thed.Washington:AmericanPsychiatricAssociation;20136.ZhangMY.[HandbookofRatingScaleinPsychiatry.2nded].Changsha:HunanScienceandTechnologyPress;1998.Chinese7.OkwuosaI,PumphreyD,PuthumanaJ,BrownM,CottsW.Impactofidentificationandtreatmentofdepressioninhearttransplantpatients.CardiovascPsychiatryNeurol.2014;2014(2014):1-6.doi:http://dx.doi.org/10.1155/2014/7472938.Fusar-PoliP,PicchioniM,MartinelliV,BhattacharyyaS,CortesiM,BaraleF,etal.Anti-depressivetherapiesafterhearttransplantation.JHeartLungTransplant.2006;25(7):785-793.doi:http://dx.doi.org/10.1016/j.healun.2006.03.0199.RustadJK,SternTA,HebertKA,MusselmanDL.Diagnosisandtreatmentofdepressioninpatientswithcongestiveheartfailure:areviewoftheliterature.PrimCareCompanionCNSDisord.2013;15(4).pii:PCC.13r01511.doi:http://dx.doi.org/10.4088/PCC.13r0151110.FraguasR,daSilvaTellesRM,AlvesTC,AndreiAM,RaysJ,IosifescuDV,etal.Adouble-blind,placebo-controlledtreatmenttrialofcitalopramformajordepressivedisorderinolderpatientswithheartfailure:therelevanceoftheplaceboeffectandpsychologicalsymptoms.ContempClinTrials.2009;30(3):205-211.doi:http://dx.doi.org/10.1016/j.cct.2009.01.00711.MochcovitchMD,NardiAE.Selectiveserotonin-reuptakeinhibitorsinthetreatmentofpanicdisorder:asystematicreviewofplacebo-controlledstudies.ExpertRevNeurother.2010;10(8):1285-1293.doi:http://dx.doi.org/10.1586/ern.10.11012.AndrisanoC,ChiesaA,SerrettiA.Newerantidepressantsandpanicdisorder:ameta-analysis.IntClinPsychopharmacol.2013;28(1):33-45.doi:http://dx.doi.org/10.1097/YIC.0b013e32835a5d2e13.WuWY.[AnxietyDisorderPreventionGuide].Beijing:People’sHealthPublishingHouse;2010.p.25.Chinese(received,2015-02-13;accepted,2015-06-15)Dr.ChenyuYegraduatedfromFudanUniversityMedicalSchoolin2001withabachelor’sdegreeinmedicine.Shesubsequentlyobtainedamaster’sdegreein2004andadoctoraldegreein2009fromFudanUniversityMedicalSchool.ShehasbeenworkingattheDepartmentofMedicalPsychology,FudanUniversityAffiliatedZhongshanHospitalsince2004andisnowanassociatechiefphysician.SheisalsoawarddirectorfortheMinhangDistrictMentalHealthCenterandtheMentalHealthCenteraffiliatedwithFudanUniversity.Hercurrentresearchinterestsarepsychiatricproblemsingeneralhospitalsandconsultation-liaisonpsychiatry.
